1933 Industries (XCNQ:TGIF) Debt-to-EBITDA : 21.17 (As of Jan. 2024)

View and export this data going back to 2008. Start your Free Trial

What is 1933 Industries Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

1933 Industries's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was C$0.59 Mil. 1933 Industries's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was C$15.92 Mil. 1933 Industries's annualized EBITDA for the quarter that ended in Jan. 2024 was C$0.78 Mil. 1933 Industries's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 was 21.17.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for 1933 Industries's Debt-to-EBITDA or its related term are showing as below:

XCNQ:TGIF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -6.61 Med: -1.42 Max: -0.7
Current: -1.75

During the past 13 years, the highest Debt-to-EBITDA Ratio of 1933 Industries was -0.70. The lowest was -6.61. And the median was -1.42.

XCNQ:TGIF's Debt-to-EBITDA is ranked worse than
100% of 655 companies
in the Drug Manufacturers industry
Industry Median: 1.66 vs XCNQ:TGIF: -1.75

1933 Industries Debt-to-EBITDA Historical Data

The historical data trend for 1933 Industries's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

1933 Industries Debt-to-EBITDA Chart

1933 Industries Annual Data

Trend

Dec14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Debt-to-EBITDA

Get a 7-Day Free Trial

-1.42

-1.81

-6.61

-1.28

-1.75

1933 Industries Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Debt-to-EBITDA	Get a 7-Day Free Trial															30.22	-1.58	-0.61	9.61	21.17

Competitive Comparison of 1933 Industries's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, 1933 Industries's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

1933 Industries's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 1933 Industries's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where 1933 Industries's Debt-to-EBITDA falls into.

1933 Industries Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

1933 Industries's Debt-to-EBITDA for the fiscal year that ended in Jul. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(4.996	+	12.575)	/	-10.033
	=	-1.75

1933 Industries's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.587	+	15.922)	/	0.78
	=	21.17

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jan. 2024) EBITDA data.

1933 Industries (XCNQ:TGIF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

1933 Industries Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of 1933 Industries's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

1933 Industries (XCNQ:TGIF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » 1933 Industries Inc (XCNQ:TGIF) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

TGIFF:USA

Address

1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 2E9

Website

https://www.1933industries.com

1933 Industries Inc is a vertically integrated cannabis company. The company is focused on the cultivation and manufacturing of cannabis consumer-branded goods. The Company operates in three segments, referred to as AMA, Infused MFG, and Corporate. AMA is focused on the cultivation and sale of medical and adult-use cannabis products, and Infused MFG is focused on the manufacturing of hemp-derived CBD products. The majority of revenue is generated from the AMA segment. The operations of AMA and Infused MFG are located in the United States. All revenues are earned in the United States.